A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain

NCT02036281 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Terminally Ill
Histologically-confirmed Advanced Cancer
Pain, Intractable

Interventions

DRUG: Substance P-Saporin

Sponsor

University of Texas Southwestern Medical Center